Risk factors for the progression of the fellow eye at patients with unilateral neovascular age-related maculadegeneratio

• Conditions: H35.3; Degeneration of macula and posterior pole

• Registration Number: DRKS00014186
• Lead Sponsor: Augenklinik Uniklinik Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

First diagnosis of neovascular AMD from 01.01.2016
- written consent of the patient
- male and female patients older than 50 years
- diagnosis of unilateral CNV in AMD
- there is an early form of AMD at the study eye at the time of inclusion

Exclusion Criteria

- first diagnosis of unilateral neovascular AMD before 01.01.2016
- bilateral late form of the AMD
- eye diseases such as glaucoma, diabetes, high myopia, CNV of other causes and macular edema of other causes
- lack of suitability for the study procedures
- pregnancy

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
When does the progression at patients with unilateral AMD of the fellow eye happen?

Secondary Outcome Measures

Name	Time	Method
Study participants with disease progression on the fellow eye vs. study participants without progression of the disease on the partner's eye, 6, 12, 18, 24 months after the initial examination.